Mehmet Baykal
Research Subjects
Research Interests
Mehmet Baykal has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ali Yağız Üresin
Division of Clinical Pharmacology, Department of Medical Pharmacology , Istanbul Faculty of Medicine, Istanbul University , Istanbul , Türkiye
1 shared publication - Belen Ateş
Department of Pediatrics, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Türkiye
1 shared publication - Bernard Tahirbegolli
Department of Management of Health Institution and Services, Heimerer College, 10000 Prishtina, Kosovo
1 shared publication - Iliriana Alloqi Tahirbegolli
Clinical Pharmacology Division, Department of Medical Pharmacology, Institute of Medical Sciences, Istanbul University , 34126 Istanbul , Turkey
1 shared publication - Selçuk Şen
Division of Clinical Pharmacology, Department of Medical Pharmacology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
1 shared publication - Yiğit Kılıç1 shared publication
Latest Publications
- Open Access
- 3 September 2019
- Published by The European Research Journal in The European Research Journal
- Vol. 5 (5) , 853-860
The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients
Objectives: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP. Methods: Seventy-eight uncontrolled BP and 98 controlled BP hypertensive patients matched on age, gender, time since hypertension diagnosis and the number of antihypertensive drugs used were investigated using a standardized questionnaire to evaluate lifestyle behaviors, drug adherence, the use of complementary and alternative medicine, and health related quality of life. Drug-drug interactions were evaluated with an electronic drug reference software. Results: Not taking therapy when feeling better was observed significantly more frequently in the uncontrolled hypertensive group (OR: 0.297, %95 CI: 0.115-0.770). Uncontrolled BP hypertensive patients live more frequently in extended family settings (p = 0.043), they sleep less controlled BP hypertensive patients (OR: 0.749, %95 CI: 0.605-0.929). The groups did not differ statistically in terms of Complementary and Alternative Medicine (CAM) use (p = 0.795) and informing doctors about the use of CAMs (p = 0.910). The EuroQol five-dimensional 3 level (EQ5D3L) questionnaire Visual Analogue Scale (VAS) score was significantly higher in the control group (p = 0.011). In both groups over 70% of patients should be monitored for therapy due to drug interactions evaluation. Conclusions: Our study shows that increasing the drug adherence and sleeping hours and living in the nuclear family is associated with improvement in blood pressure control and health related quality of life. A comprehensive approach and good patient-physician communication and trust are essential for well-managed hypertension.
- 3 September 2019
- Published by The European Research Journal in The European Research Journal
- Vol. 5 (5) , 853-860
Open AccessThe drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients
Objectives: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP. Methods: Seventy-eight uncontrolled BP and 98 controlled BP hypertensive patients matched on age, gender, time since hypertension diagnosis and the number of antihypertensive drugs used were investigated using a standardized questionnaire to evaluate lifestyle behaviors, drug adherence, the use of complementary and alternative medicine, and health related quality of life. Drug-drug interactions were evaluated with an electronic drug reference software. Results: Not taking therapy when feeling better was observed significantly more frequently in the uncontrolled hypertensive group (OR: 0.297, %95 CI: 0.115-0.770). Uncontrolled BP hypertensive patients live more frequently in extended family settings (p = 0.043), they sleep less controlled BP hypertensive patients (OR: 0.749, %95 CI: 0.605-0.929). The groups did not differ statistically in terms of Complementary and Alternative Medicine (CAM) use (p = 0.795) and informing doctors about the use of CAMs (p = 0.910). The EuroQol five-dimensional 3 level (EQ5D3L) questionnaire Visual Analogue Scale (VAS) score was significantly higher in the control group (p = 0.011). In both groups over 70% of patients should be monitored for therapy due to drug interactions evaluation. Conclusions: Our study shows that increasing the drug adherence and sleeping hours and living in the nuclear family is associated with improvement in blood pressure control and health related quality of life. A comprehensive approach and good patient-physician communication and trust are essential for well-managed hypertension.